Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004184283 | SCV003677439 | uncertain significance | not specified | 2022-08-02 | criteria provided, single submitter | clinical testing | The c.2020G>C (p.E674Q) alteration is located in exon 15 (coding exon 15) of the SPTA1 gene. This alteration results from a G to C substitution at nucleotide position 2020, causing the glutamic acid (E) at amino acid position 674 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003738331 | SCV004548826 | benign | not provided | 2023-11-13 | criteria provided, single submitter | clinical testing |